Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers
Simon J. Cooper, Christina A. Von Roemeling, Kylie H. Kang, Laura A. Marlow, Stefan K. Grebe, Michael E. Menefee, Han W. Tun, Gerardo Colon-Otero, Edith A. Perez, John A. Copland
Dive into the research topics of 'Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers'. Together they form a unique fingerprint.